The United States Food and Drug Administration issued a Black Box warning in October 2004 after placebo-controlled trials of antidepressant medications found an increased risk of suicidal thoughts and behaviors among children and adolescents taking antidepressant medications relative to placebo. Subsequently, some researchers have concluded that the Black Box warning caused severe unintended consequences; specifically, they have argued that the warning led to reduced use of antidepressants among youth, which led to more suicides. In this paper, we critically examine research regarding the Black Box warning’s alleged deleterious consequences. One study claimed that controlled trials did not actually find an increased risk of suicidality amon...
In the past few years several papers have reported critically on the risk of suicidal thoughts and b...
Objective: The purpose of this review is to assess whether evidence supports a favorable risk/benefi...
Full Text: To The Editor: Dr. Gibbons et al. concluded that regulators\u92 suicidality warning on SS...
Introduction: The first published literature on the topic of antidepressants and suicidality dates b...
The decision made in the year 2004 by the U.S. Food and Drug Administration (FDA) to require a boxed...
The decision made in the year 2004 by the U.S. Food and Drug Administration (FDA) to require a boxed...
The decision made in the year 2004 by the U.S. Food and Drug Administration (FDA) to require a boxed...
Background The United States Food and Drug Administration (FDA) has warned about the increased suic...
Prompted by psychiatrists with their own vested interests in pharmaceutical sales, the media has spu...
and Drug Administration (FDA) warned physicians and patients regarding in-creased risk of suicide wi...
The topic of whether antidepressant drugs increase or decrease the risk of various aspects of "suici...
Full Text: JON JUREIDINI, M.B.B.S., F.R.A.N.Z.C.P., Ph.D. British Columbia, Canada To The Editor: ...
The association of antidepressants with suicidal thought in people aged up to 25 year is a thorny is...
textabstractObjective: Prior research evaluated various effects of the 2004 black-box warning by the...
Objective: The purpose of this review is to assess whether evidence supports a favorable risk/benefi...
In the past few years several papers have reported critically on the risk of suicidal thoughts and b...
Objective: The purpose of this review is to assess whether evidence supports a favorable risk/benefi...
Full Text: To The Editor: Dr. Gibbons et al. concluded that regulators\u92 suicidality warning on SS...
Introduction: The first published literature on the topic of antidepressants and suicidality dates b...
The decision made in the year 2004 by the U.S. Food and Drug Administration (FDA) to require a boxed...
The decision made in the year 2004 by the U.S. Food and Drug Administration (FDA) to require a boxed...
The decision made in the year 2004 by the U.S. Food and Drug Administration (FDA) to require a boxed...
Background The United States Food and Drug Administration (FDA) has warned about the increased suic...
Prompted by psychiatrists with their own vested interests in pharmaceutical sales, the media has spu...
and Drug Administration (FDA) warned physicians and patients regarding in-creased risk of suicide wi...
The topic of whether antidepressant drugs increase or decrease the risk of various aspects of "suici...
Full Text: JON JUREIDINI, M.B.B.S., F.R.A.N.Z.C.P., Ph.D. British Columbia, Canada To The Editor: ...
The association of antidepressants with suicidal thought in people aged up to 25 year is a thorny is...
textabstractObjective: Prior research evaluated various effects of the 2004 black-box warning by the...
Objective: The purpose of this review is to assess whether evidence supports a favorable risk/benefi...
In the past few years several papers have reported critically on the risk of suicidal thoughts and b...
Objective: The purpose of this review is to assess whether evidence supports a favorable risk/benefi...
Full Text: To The Editor: Dr. Gibbons et al. concluded that regulators\u92 suicidality warning on SS...